These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26708741)

  • 1. The emerging role of RUNX3 in cancer metastasis (Review).
    Chen F; Liu X; Bai J; Pei D; Zheng J
    Oncol Rep; 2016 Mar; 35(3):1227-36. PubMed ID: 26708741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of RUNX3 in human carcinogenesis.
    Subramaniam MM; Chan JY; Yeoh KG; Quek T; Ito K; Salto-Tellez M
    Biochim Biophys Acta; 2009 Dec; 1796(2):315-31. PubMed ID: 19682550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers.
    Ito K
    J Cell Biochem; 2011 May; 112(5):1243-9. PubMed ID: 21465522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
    Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
    Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
    Kim BR; Kang MH; Kim JL; Na YJ; Park SH; Lee SI; Kang S; Joung SY; Lee SY; Lee DH; Min BW; Oh SC
    Oncol Rep; 2016 Nov; 36(5):2601-2608. PubMed ID: 27633042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
    Han YX; Liang DY
    Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
    Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
    Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.
    Shiraha H; Nishina S; Yamamoto K
    J Cell Biochem; 2011 Mar; 112(3):745-9. PubMed ID: 21328447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic role of RUNX3 in head and neck cancer.
    Kudo Y; Tsunematsu T; Takata T
    J Cell Biochem; 2011 Feb; 112(2):387-93. PubMed ID: 21268058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
    Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
    Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor function of RUNX3 in breast cancer.
    Chen LF
    J Cell Biochem; 2012 May; 113(5):1470-7. PubMed ID: 22275124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx3 in Immunity, Inflammation and Cancer.
    Lotem J; Levanon D; Negreanu V; Bauer O; Hantisteanu S; Dicken J; Groner Y
    Adv Exp Med Biol; 2017; 962():369-393. PubMed ID: 28299669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
    Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX3 modulates hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells.
    Liu Y; Zou J; Li B; Wang Y; Wang D; Hao Y; Ke X; Li X
    Int J Mol Med; 2017 Jul; 40(1):65-74. PubMed ID: 28534977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol promotes alcohol-related colorectal cancer metastasis via the TGF-β/RUNX3/Snail axis by inducing TGF-β1 upregulation and RUNX3 cytoplasmic mislocalization.
    Zheng K; Yu J; Chen Z; Zhou R; Lin C; Zhang Y; Huang Z; Yu L; Zhao L; Wang Q
    EBioMedicine; 2019 Dec; 50():224-237. PubMed ID: 31757777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
    Chuang LS; Ito Y
    Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.